These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 31375581)
1. Endosomal Toll-Like Receptors Mediate Enhancement of Interleukin-17A Production Triggered by Epstein-Barr Virus DNA in Mice. Shehab M; Sherri N; Hussein H; Salloum N; Rahal EA J Virol; 2019 Oct; 93(20):. PubMed ID: 31375581 [TBL] [Abstract][Full Text] [Related]
2. Endosomal Toll-Like Receptors (TLRs) mediate enhancement of IL-17A production triggered by Epstein-Barr virus (EBV) DNA in mice. Shehab M; Jammaz R; Salloum N; Rahal EA J Infect Dev Ctries; 2018 Feb; 12(2.1):26S. PubMed ID: 31805001 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus DNA modulates regulatory T-cell programming in addition to enhancing interleukin-17A production via Toll-like receptor 9. Salloum N; Hussein HM; Jammaz R; Jiche S; Uthman IW; Abdelnoor AM; Rahal EA PLoS One; 2018; 13(7):e0200546. PubMed ID: 29995930 [TBL] [Abstract][Full Text] [Related]
4. The Effects of Endosomal Toll-like Receptor Inhibitors in an EBV DNA-Exacerbated Inflammatory Bowel Disease Mouse Model. Karout I; Salhab Z; Sherri N; Bitar ER; Borghol AH; Sabra H; Kassem A; Osman O; Alam C; Znait S; Assaf R; Fadlallah S; Jurjus A; Hashash JG; Rahal EA Viruses; 2024 Apr; 16(4):. PubMed ID: 38675965 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus DNA Exacerbates Arthritis in a Mouse Model via Toll-like Receptor 9. Sherri N; Assaf R; Bitar ER; Znait S; Borghol AH; Kassem A; Rahal EA Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731877 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr Virus and Human herpes virus 6 Type A DNA Enhance IL-17 Production in Mice. Rahal EA; Hajjar H; Rajeh M; Yamout B; Abdelnoor AM Viral Immunol; 2015 Jun; 28(5):297-302. PubMed ID: 25870901 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus DNA Exacerbates Colitis Symptoms in a Mouse Model of Inflammatory Bowel Disease. Andari S; Hussein H; Fadlallah S; Jurjus AR; Shirinian M; Hashash JG; Rahal EA Viruses; 2021 Jun; 13(7):. PubMed ID: 34210024 [TBL] [Abstract][Full Text] [Related]
8. An IL-17A-centric response to Epstein-Barr virus DNA mediated by dendritic Cell-T cell interactions. Shehab M; Hussein H; Fadlallah S; Rahal EA Front Mol Biosci; 2024; 11():1243366. PubMed ID: 38638687 [No Abstract] [Full Text] [Related]
9. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection. Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling. van Gent M; Braem SG; de Jong A; Delagic N; Peeters JG; Boer IG; Moynagh PN; Kremmer E; Wiertz EJ; Ovaa H; Griffin BD; Ressing ME PLoS Pathog; 2014 Feb; 10(2):e1003960. PubMed ID: 24586164 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes. Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863 [TBL] [Abstract][Full Text] [Related]
13. Host factors associated with the kinetics of Epstein-Barr virus DNA load in patients with primary Epstein-Barr virus infection. Nakai H; Kawamura Y; Sugata K; Sugiyama H; Enomoto Y; Asano Y; Ihira M; Ohashi M; Kato T; Yoshikawa T Microbiol Immunol; 2012 Feb; 56(2):93-8. PubMed ID: 22150751 [TBL] [Abstract][Full Text] [Related]
14. Effect of Epstein-Barr Virus DNA on the Incidence and Severity of Arthritis in a Rheumatoid Arthritis Mouse Model. Fadlallah S; Hussein H; Jallad MA; Shehab M; Jurjus AR; Matar GM; Rahal EA Front Immunol; 2021; 12():672752. PubMed ID: 34040613 [TBL] [Abstract][Full Text] [Related]
15. Immune activation suppresses initiation of lytic Epstein-Barr virus infection. Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714 [TBL] [Abstract][Full Text] [Related]
16. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Niller HH; Wolf H; Minarovits J Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410 [TBL] [Abstract][Full Text] [Related]
17. Gene profiling of Epstein-Barr Virus and human endogenous retrovirus in peripheral blood mononuclear cells of SLE patients: immune response implications. Lemus YB; Martínez GA; Lugo LP; Escorcia LG; Peñata EZ; Llanos NS; Bonfanti AC; Acosta-Hoyos AJ; Quiroz EN Sci Rep; 2024 Aug; 14(1):20236. PubMed ID: 39215087 [TBL] [Abstract][Full Text] [Related]
18. The influence of toll-like receptor stimulation on expression of EBV lytic genes. Siennicka J; Trzcińska A; Cześcik A; Dunal-Szczepaniak M; Lagosz B Pol J Microbiol; 2013; 62(3):237-42. PubMed ID: 24459828 [TBL] [Abstract][Full Text] [Related]
19. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription. Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients. Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]